The National Agency for Food and Drug Administration and Control (NAFDAC) has said that the new Executive Order signed by President Bola Tinubu is aimed at transforming the country’s healthcare sector by increasing local production of healthcare products, and promoting local investments.
Minister of Health and Social Welfare, Prof. Mohammed Ali Pate, had said that the Executive Order will reduce barriers related to the import of raw materials and equipment for pharmaceuticals and medical devices.
He said the policy change will enable Nigerians to produce essential items domestically, such as syringes, needles, generic pharmaceuticals, test kits, and long-lasting insecticide treated nets for malaria.
Director-general of NAFDAC, Prof. Mojisola Adeyeye, said zero tariffs and excise duties for specified pharmaceutical machinery, equipment, goods, and accessories are part of the measures included in the Executive Order.
Prof. Adeyeye, who disclosed this in a statement on Saturday, said the Executive Order aims to reduce the prohibitive costs of medicines and other pharmaceutical products, making healthcare more affordable for Nigerians.
She said: “Encouraging local manufacturing will create jobs, stimulate economic growth, and reduce dependence on imports, ensuring a reliable supply of essential healthcare products.
“The President’s EO underscores his administration’s commitment to transforming Nigeria’s health sector. It aligns with the broader objectives of the NHSRII and the Presidential Initiative on Healthcare Value Chain (PVAC), approved in October 2023.
“By addressing core challenges and providing a clear path for improvement, this EO sets the stage for a sustainable and high-quality healthcare system for all Nigerians.”
